Patents by Inventor John B. Lasekan

John B. Lasekan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nutritional products including a novel fat system including fatty acids
    Patent number: 9844517
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: December 19, 2017
    Assignee: ABBOTT LABORATORIES
    Inventors: Chron-Si Lai, John B. Lasekan, Gary E. Katz, Christopher T. Cordle
  • Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
    Patent number: 9446005
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: September 20, 2016
    Assignee: Abbott Laboratories
    Inventors: Chron-Si Lai, Keith A. Garleb, John B. Lasekan, Steven R. Davis, Christopher T. Cordle, Russell J. Merritt
  • Nutritional products including monoglycerides and fatty acids
    Patent number: 9078846
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: July 14, 2015
    Assignee: ABBOTT LABORATORIES
    Inventors: Chron-Si Lai, John B. Lasekan, Christopher T. Cordle
  • NUTRITIONAL PRODUCTS INCLUDING A NOVEL FAT SYSTEM INCLUDING FATTY ACIDS
    Publication number: 20150132466
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Application
    Filed: January 20, 2015
    Publication date: May 14, 2015
    Applicant: ABBOTT LABORATORIES
    Inventors: CHRON-SI LAI, JOHN B. LASEKAN, GARY E. KATZ, CHRISTOPHER T. CORDLE
  • Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
    Patent number: 8877812
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: November 4, 2014
    Assignee: Abbott Laboratories
    Inventors: Chron-Si Lai, Keith A. Garleb, John B. Lasekan, Steven R. Davis
  • METHODS FOR IMPROVING TOLERANCE, DIGESTION, AND LIPID SOLUBLE NUTRIENT ABSORPTION IN AN INFANT, TODDLER, OR CHILD
    Publication number: 20140249224
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Application
    Filed: May 9, 2014
    Publication date: September 4, 2014
    Applicant: ABBOTT LABORATORIES
    Inventors: CHRON-SI LAI, KEITH A. GARLEB, JOHN B. LASEKAN, STEVEN R. DAVIS, CHRISTOPHER T. CORDLE, RUSSELL J. MERRITT
  • Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
    Patent number: 8754126
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: June 17, 2014
    Assignee: Abbott Laboratories
    Inventors: Chron-Si Lai, Keith A. Garleb, John B. Lasekan, Steven R. Davis, Christopher T. Cordle, Russell J. Merritt
  • NUTRITIONAL PRODUCTS INCLUDING A NOVEL FAT SYSTEM INCLUDING FATTY ACIDS
    Publication number: 20120172445
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Application
    Filed: December 21, 2011
    Publication date: July 5, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Chron-Si Lai, John B. Lasekan, Gary E. Katz, Christopher T. Cordle
  • NUTRITIONAL PRODUCTS INCLUDING MONOGLYCERIDES AND FATTY ACIDS
    Publication number: 20120171350
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Application
    Filed: December 21, 2011
    Publication date: July 5, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Chron-Si Lai, John B. Lasekan, Christopher T. Cordle
  • METHODS FOR IMPROVING TOLERANCE, DIGESTION, AND LIPID SOLUBLE NUTRIENT ABSORPTION IN AN INFANT, TODDLER, OR CHILD
    Publication number: 20120172434
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Application
    Filed: December 21, 2011
    Publication date: July 5, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Chron-Si Lai, Keith A. Garleb, John B. Lasekan, Steven R. Davis, Christopher T. Cordle, Russell J. Merritt
  • METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS, COLIC, AND SHORT BOWEL SYNDROME IN AN INFANT, TODDLER, OR CHILD
    Publication number: 20120172442
    Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
    Type: Application
    Filed: December 21, 2011
    Publication date: July 5, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Chron-Si Lai, Keith A. Garleb, John B. Lasekan, Steven R. Davis
  • Soy Protein-Based Nutritional Formula with Superior Stability
    Publication number: 20110129573
    Abstract: The present disclosure relates to soy protein-based powdered nutritional formulas, such as infant or toddler formulas, that contain lutein and fructooligosaccharide (FOS). The FOS stabilizes lutein present in the formula, resulting in less lutein degradation over the shelf-life of the formula. When fed to infants, the nutritional formulas provide an infant stool pattern, frequency, and color more closely resembling that of breastfed infants.
    Type: Application
    Filed: November 22, 2010
    Publication date: June 2, 2011
    Inventors: Daniel S. Albrecht, John B. Lasekan
  • Method for improving bone mineralization
    Patent number: 6849268
    Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.
    Type: Grant
    Filed: August 12, 2003
    Date of Patent: February 1, 2005
    Assignee: Abbott Laboratories
    Inventors: John B. Lasekan, Marc L. Masor, Michael B. Montalto, John D. Benson
  • Method for improving bone mineralization
    Publication number: 20040062820
    Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.
    Type: Application
    Filed: August 12, 2003
    Publication date: April 1, 2004
    Inventors: John B. Lasekan, Marc L. Masor, Michael B. Montalto, John D. Benson
  • Method for improving bone mineralization
    Patent number: 6620427
    Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: September 16, 2003
    Assignee: Abbott Laboratories
    Inventors: John B. Lasekan, Marc L. Masor, Michael B. Montalto, John D. Benson
  • Anti-regurgitation formula and uses thereof
    Publication number: 20030165606
    Abstract: It has been discovered that reducing the amount of lactose in standard non-soy protein based infant formulas will help to alleviate the regurgitation that is commonly experienced by infants during the first six to twelve months of life. Lactose levels should be 75 wt/wt %, or less, of the carbohydrate component.
    Type: Application
    Filed: July 11, 2002
    Publication date: September 4, 2003
    Inventors: John B. Lasekan, Julia A. Byard, Mary P. Franz, Hawley K. Linke
  • Method for improving bone mineralization
    Publication number: 20030026860
    Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.
    Type: Application
    Filed: June 8, 2001
    Publication date: February 6, 2003
    Inventors: John B. Lasekan, Marc L. Masor, Michael B. Montalto, John D. Benson